ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

Report Says Many Cancers Could Be Prevented

February 27, 2009

caBIG Architect Kenneth Buetow Resigns

December 16, 2011

Clinical Trials Approved By NCI

September 26, 2003

New Group Review First NTP Reports, Gets Job On Permanent Basis, Wrangles Over Extrapolation

July 11, 1980

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011